0001209191-16-138303.txt : 20160823
0001209191-16-138303.hdr.sgml : 20160823
20160823161808
ACCESSION NUMBER: 0001209191-16-138303
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160819
FILED AS OF DATE: 20160823
DATE AS OF CHANGE: 20160823
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioTelemetry, Inc.
CENTRAL INDEX KEY: 0001574774
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 462568498
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 227 WASHINGTON STREET #210
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
BUSINESS PHONE: 610-729-7000
MAIL ADDRESS:
STREET 1: 227 WASHINGTON STREET #210
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Capper Joseph H
CENTRAL INDEX KEY: 0001456817
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55039
FILM NUMBER: 161847414
MAIL ADDRESS:
STREET 1: HOME DIAGNOSTICS, INC.
STREET 2: 2400 NW 55TH COURT
CITY: FORT LAUDERDALE
STATE: FL
ZIP: 33309
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-08-19
0
0001574774
BioTelemetry, Inc.
BEAT
0001456817
Capper Joseph H
1000 CEDAR HOLLOW ROAD
SUITE 102
MALVERN
PA
19355
1
1
0
0
President and CEO
Common Stock
2016-08-19
4
S
0
9049
20.96
D
568857
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2016
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from 20.54 to 21.25, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
/s/ Jason D. Herpel, by power of Attorney
2016-08-23
EX-24.4_672337
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents that the undersigned hereby constitutes and appoints
each of Peter Ferola and Jason Herpel, signing individually, the undersigned's
true and lawful attorneys-in-fact and agents to:
(1) execute for and on behalf of the undersigned, an officer, director or holder
of 10% of more of a registered class of securities of BioTelemetry, Inc. (the
"Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute such Form 3, 4 or 5,
complete and execute any amendment or amendments thereto, and timely file such
forms or amendments with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact
individually, until such attorney-in-fact shall no longer be employed by the
Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 18th day of August, 2016.
/s/ Joseph H. Capper